New Products: Meso Scale, Bio-Rad, and More | GenomeWeb

Meso Scale Discovery has released its S-PLEX immunoassay platform, which, the company said, is 1,000 times more sensitive than existing ELISA technologies and can detect analytes at concentrations below 1 femtogram per mL.

The company currently offers the platform as an assay development service, but plans in the near future to offer S-PLEX assays in kits compatible with its existing Sector and QuickPlex instruments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.